During the past decade, Lungenklinik Hemer conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lungenklinik Hemer" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Aeris Therapeutics" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lungenklinik Hemer" #1 collaborator was "PneumRx, Inc." with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Lungenklinik Hemer" are "Carcinoma, Non-Small-Cell Lung" (8 trials), "Emphysema" (7 trials), "Non-Small Cell Lung Cancer" (3 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Lungenklinik Hemer" in a lesser frequency.

Most popular intervention types in "Lungenklinik Hemer" are "Drug" (24 trials), "Device" (12 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Pemetrexed" (6 trials), "Cisplatin" (5 trials), "Erlotinib" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lungenklinik Hemer" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Lungenklinik Hemer". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Lungenklinik Hemer, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Lungenklinik Hemer, 6 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Lungenklinik Hemer has several departments that took part in Clinical trials: "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" - 2 trials